Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Hay
Progressive Resistance of BTK-143 Osteosarcoma Cells to Apo2L/TRAIL-induced Apoptosis Is Mediated by Acquisition of DcR2/TRAIL-R4 Expression: Resensitisation With Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Related publications
Potential Mechanisms of Resistance to TRAIL/Apo2L-induced Apoptosis in Human Promyelocytic Leukemia HL-60 Cells During Granulocytic Differentiation
Cell Death and Differentiation
Cell Biology
Molecular Biology
Resistance of Prostate Cancer Cells to Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL/Apo2L) Can Be Overcome by Doxorubicin or Adenoviral Delivery of Full-Length TRAIL
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis
International Journal of Oncology
Cancer Research
Oncology
Surface TRAIL Decoy Receptor-4 Expression Is Correlated With TRAIL Resistance in McF7 Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Bufalin Sensitizes Human Bladder Carcinoma Cells to TRAIL-mediated Apoptosis
Oncology Letters
Cancer Research
Oncology
N-Glycosylation of Mouse TRAIL-R Restrains TRAIL-induced Apoptosis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
MUC16 Mucin (CA125) Attenuates TRAIL-induced Apoptosis by Decreasing TRAIL Receptor R2 Expression and Increasing C-Flip Expression
BMC Cancer
Cancer Research
Oncology
Genetics
Enhanced Tumor Killing by Apo2L/Trail and CPT-11 Co-Treatment Is Associated With P21 Cleavage and Differential Regulation of Apo2L/Trail Ligand and Its Receptors
Oncogene
Cancer Research
Genetics
Molecular Biology
Downregulation of DcR3 Sensitizes Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis
OncoTargets and Therapy
Oncology
Pharmacology
